Scientific Program - Thursday 22 February

Print
Please see below the CODHy Scientific Program. Please click on the appropriate day to view the relevant program. To view the program timetable / overview, please click here
 
   
Wednesday 21 February, 2018 Thursday 22 February
Thursday 22 February, 2018
HALL A
09:00-11:00
09:00-09:05
09:05-09:25
09:25-09:45
09:45-10:05

10:05-10:25
10:25-10:45

10:45-11:00
SESSION 11 – DIGITAL THERAPY | KEY NOTE LECTURES               
Chairpersons: Ronni Gamzu, Israel and Julio Wainstein, Israel
Using AI to improve diabetes management: Ronni Gamzu, Israel
Digital medicine – Advantages and limitations: Mordechai Shani, Israel
Big data, Cloud and Machine Learning – advantage and short come: Dov Moran, Israel
How to Win-Win-Win in digital health: Adam Higgins, UK
The evolution of data generation strategies for new diabetes treatments: Riccardo Perfetti, USA
Discussion
11:00-11:30
COFFEE BREAK
HALL A
11:30-13:00
SESSION 12 – DIGITAL THERAPY SYMPOSIUM I
HALL B
11:30-13:00
11:30-11:35


11:35-11:50
11:50-12:05

12:05-12:20
12:20-12:35
12:35-13:00
SESSION 13 – HYPERTENSION II
Chairperson: Ehud Grossman, Israel and Yoel Toledano, Israel
Should the guidelines favor dual combination therapy in the initial treatment of hypertension?
Yes: Ehud Grossman, Israel
No: Talia Wolak, Israel
Should we lower the target systolic BP to 120 mm Hg?
Yes: Naftali Stern, Israel
No: Roy Eldor, Israel
Discussion
HALL C
11:30-13:00
11:30-11:35

11:35-12:15

12:15-12:35
12:35-13:00
SESSION 14 – FIGHTING OBESITY
Chairperson: Naim Shehadeh, Israel, Genia Aharon-Hananel, Israel and Luc Van Gaal, Belgium 
Metabolic surgery for primary & secondary diabetes prevention: Luc Van Gaal, Belgium
Thyroid function in weight gain: Qu Shen, China 
Discussion
13:00-14:00
LUNCH
HALL A
14:00-15:30
SESSION 15 – DIGITAL THERAPY SYMPOSIUM II
HALL B
14:00-15:30
14:00-14:05
14:05-14:25
14:25-14:45
14:45-15:00
 
15:00-15:30
SESSION 16 – BE AWARE OF….
Chairperson: Robert Niecestro, USA and Boaz Hirshberg, USA
Drug safety and efficacy: Boaz Hirshberg, USA
Hypoglycaemia: Simon Heller, UK
A randomized controlled trial of ORMD 0801 oral insulin in patients with type 2 diabetes: Roy Eldor, Israel
Discussion
HALL C
14:00-15:30
14:00-14:05
14:05-14:25

14:25-14:45
14:45-15:05
15:05-15:30
SESSION 17 – RESIDUAL CV RISK IN DIABETES
Chairperson: Anat Tzur, Israel and Alberto Zambon, Italy
Non-HDL cholesterol: Alberto Zambon, Italy
How low we want LDL- Cholesterol?
Big data: Ran Goshen, Israel
RCT data: Itamar Raz, Israel
Discussion
15:30-16:00
COFFEE BREAK
HALL A
16:00-17:30
SESSION 18 - DIGITAL THERAPY SYMPOSIUM III
HALL B
16:00-17:30
16:00-16:05
16:05-16:25
16:25-16:45
16:45-17:05
17:05-17:30
SESSION 19 – TREATMENT EVOLUTION IN TYPE 1 DIABETES
Chairperson: Orna Dally Gottfried, Israel and Gil Leibowitz, Israel
New insulins: Yang Tao, China
The artificial pancreas: Are we there? Moshe Philip, Israel
Beta cell replacement: Yong De Peng, China
Discussion
HALL C
16:00-17:30
16:00-16:05
16:05-16:35
16:35-17:05
17:05-17:30
SESSION 20 – DIABETES AND HEART FAILURE
Chairperson: Hilla Knobler, Israel and Angelo Avogaro, Italy
Diabetic cardiomyopathy: Angelo Avogaro, Italy
HF and anti-hyperglycemic drugs: Mikhail Kosiborod, USA
Discussion
17:30-18:30
FAREWELL NETWORKING RECEPTION